Crafting Strategic Pathways for MedTech Market Success

• Tailored Reimbursement Strategies: Customised approaches for effective reimbursement plan development and implementation.
• Evidence-Based Market Entry: Assistance in gathering and presenting compelling clinical and economic evidence.
• Standard of Care Analysis: Strategies that consider existing standards of care, showcasing the value add of new products.
• Guidance for NICE HTA Submission: Expertise in preparing and guiding through NICE HTA submissions, ensuring compliance and maximising chances of a favourable review.
• NHS Integration: Specialised knowledge in aligning strategies with NHS requirements and frameworks.
• Regulatory Navigation: Expert guidance on meeting stringent regulatory demands for market access.
• Bridging the Evidence Gap: Identifying and addressing any gaps between current evidence and what is required for successful NICE HTA submission.

Q: How do you integrate reimbursement planning into strategy development?

• A: We assess the reimbursement landscape, aligning our strategies with payer requirements to optimise reimbursement potential.

Q: Can you assist in compiling evidence for health technology assessments?

• A: Yes, we support in gathering and structuring evidence for health technology assessments to demonstrate the efficacy and cost-effectiveness of products.

Q: How does your strategy address the comparison with standard care?

• A: Our strategies include a comprehensive analysis of existing care standards, ensuring that new products offer clear advantages and align with current clinical practices.

Q: What methods do you use for evidence collection and analysis?

• A: We employ a variety of methods, including clinical trials data analysis, real-world evidence collection, and systematic literature reviews, to gather robust evidence.

Q: How do you ensure that strategies are adaptable to evolving healthcare environments?

• A: Our strategies are designed with flexibility in mind, allowing for adjustments in response to changes in healthcare policies, market dynamics, and emerging technologies.

Q: In what ways do you support companies in meeting economic requirements?

• A: We assist in conducting cost-effectiveness analyses, budget impact models, and pricing strategies to meet economic requirements and demonstrate value.

Q: How do you support the preparation for a NICE HTA submission?

A: We assist in the entire process, from evidence gathering, cost-effectiveness analysis, to submission strategy, ensuring a comprehensive and well-prepared NICE HTA submission.

Q: What strategies do you employ to bridge the evidence gap for NICE submissions?

• A: We identify specific areas where additional evidence is needed and assist in designing studies or collecting data to fill these gaps effectively.